Pediatric Allergy
Response to peanut patch treatment increases through 60 months
SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.
Patients introduce allergens into their diets after using omalizumab
SAN DIEGO — Patients with multiple food allergies introduced allergens into their diets after using omalizumab, researchers reported at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Food allergy anxiety deemed a unique subtype with high youth, caregiver concordance
SAN DIEGO — Food allergy anxiety is a unique subtype of anxiety that merits specific assessment and tailored interventions, according to an abstract presented here.
Food allergy less common among children with cystic fibrosis
SAN DIEGO — In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, which was a lower proportion than the general pediatric population, according to a presentation here.
Families ‘thrilled’ with omalizumab in the year since its approval for food allergy
As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert A. Wood, MD, FAAAAI, professor of pediatrics, Johns Hopkins University School of Medicine, told Healio.
Patient, clinical characteristics linked to total serum IgE in children with food allergy
Researchers have discovered significant links between total serum IgE in children with food allergy and several patient factors, according to results published in The Journal of Allergy and Clinical Immunology: In Practice.
ARS Pharma to provide free neffy epinephrine nasal spray to schools
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with two cartons of the company’s neffy epinephrine nasal spray, including a total of four single-use doses, for free.
Diverse diet at age 9 months indicates less risk for food allergy at age 18 months
Infants with a diverse diet at age 9 months were less likely to develop food allergy by age 18 months, especially if they had a history of eczema, according to a study published by Pediatric Allergy and Immunology.
Dupilumab does not desensitize children with peanut allergy
Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to results published in Allergy.
Children with food allergy face ‘substantial’ psychosocial burden
Children with food allergy face a substantial psychosocial burden regardless of their sociodemographic or clinical characteristics, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.